Log in

Relevant bibliographies by topics / Oral oncology / Journal articles

To see the other types of publications on this topic, follow the link: Oral oncology.

Journal articles on the topic 'Oral oncology'

Author: Grafiati

Published: 8 September 2021

Last updated: 29 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Oral oncology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Scully, Crispian. "Oral oncology." European Journal of Cancer and Clinical Oncology 27, no. 11 (1991): 1341. http://dx.doi.org/10.1016/0277-5379(91)90002-u.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

JOHNS, M. E. "Oral Oncology." Archives of Otolaryngology - Head and Neck Surgery 111, no. 6 (1985): 417. http://dx.doi.org/10.1001/archotol.1985.00800080103021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Scully, Crispian, and Sarah Jenkins. "Oral Oncology E-pages." Oral Oncology 45, no. 1 (2009): 1. http://dx.doi.org/10.1016/j.oraloncology.2008.11.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Peckham, Michael. "EJC expands: Oral oncology." European Journal of Cancer and Clinical Oncology 27, no. 11 (1991): 1341. http://dx.doi.org/10.1016/0277-5379(91)90001-t.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rapidis, Alexander D., and Crispian Scully. "Oral oncology: imagine the future." Future Oncology 5, no. 8 (2009): 1221–23. http://dx.doi.org/10.2217/fon.09.102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

SCULLY, C. "International Academy of Oral Oncology." Oral Oncology 41, no. 5 (2005): 439. http://dx.doi.org/10.1016/j.oraloncology.2005.04.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Scully, Crispian, and Jose V. Bagan. "Recent advances in Oral Oncology." Oral Oncology 43, no. 2 (2007): 107–15. http://dx.doi.org/10.1016/j.oraloncology.2006.12.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Cohen, Ezra. "The evolution of Oral Oncology." Oral Oncology 47, no. 1 (2011): 1. http://dx.doi.org/10.1016/j.oraloncology.2011.01.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Borras, N. "8045 INVITED Oral oncology agents." European Journal of Cancer Supplements 5, no. 4 (2007): 424. http://dx.doi.org/10.1016/s1359-6349(07)71549-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Scully, Crispian. "Oral oncology: 5 years' progress." European Journal of Cancer Part B: Oral Oncology 32, no. 1 (1996): 1–2. http://dx.doi.org/10.1016/0964-1955(96)00004-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Rapidis, Alexander D., and Crispian Scully. "Recent Advances in Oral Oncology." European Oncology & Haematology 05, no. 01 (2009): 25. http://dx.doi.org/10.17925/eoh.2009.05.1.25.

Full text

Abstract:

Oral cancer is becoming increasingly common and new risk factors have been recognised. Treatment remains largely surgical, but radiotherapy and, increasingly, chemotherapy and targeted therapy have roles to play.

APA, Harvard, Vancouver, ISO, and other styles

12

Singh, AkhileshKumar. "Our challenges in practicing oral oncology." National Journal of Maxillofacial Surgery 11, no. 1 (2020): 1. http://dx.doi.org/10.4103/njms.njms_87_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

A.S, Dr Sreedevi, Dr D. Thamaraiselvi, Dr V. Veeravarmal, and Dr R. Amsaveni. "Advanced Techniques In Oral Oncology: AComprehensiveReview." IOSR Journal of Dental and Medical Sciences 23, no. 10 (2024): 56–61. http://dx.doi.org/10.9790/0853-2310045661.

Full text

Abstract:

The most common type of oral cancer, oral squamous cell carcinoma (OSCC), is still amajor global health concern. Due to delayed diagnoses, which are frequently caused by low public awareness and fewscreeningalternatives, the five-year survival rate is still low. Modernmethods in oral oncology have arisen to enhance patient outcomes and early identification, including as molecular and imaging diagnostics. This review showcases several cutting-edge diagnostic techniques, including flow cytometry, next-generation sequencing(NGS), chemiluminescence, toluidine blue, immunohistochemistry (IHC), fluo

APA, Harvard, Vancouver, ISO, and other styles

14

Scully, Crispian. "The real impact of oral oncology." Oral Oncology 44, no. 5 (2008): 423–24. http://dx.doi.org/10.1016/j.oraloncology.2008.03.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Scully, Crispian. "Oral oncology editorial: Coming of age." Oral Oncology 46, no. 1 (2010): 1–3. http://dx.doi.org/10.1016/j.oraloncology.2009.10.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Porter, S. R., and J. Jorge Jr. "Thalidomide: a role in oral oncology?" Oral Oncology 38, no. 6 (2002): 527–31. http://dx.doi.org/10.1016/s1368-8375(01)00114-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Ettinger, Kyle S., and Jacob G. Yetzer. "Controversies in Oral and Maxillofacial Oncology." Oral and Maxillofacial Surgery Clinics of North America 29, no. 4 (2017): 487–501. http://dx.doi.org/10.1016/j.coms.2017.07.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Peterson, Douglas E. "Oral Mucosal Injury in Oncology Patients." Current Oral Health Reports 1, no. 3 (2014): 190–95. http://dx.doi.org/10.1007/s40496-014-0025-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Fantozzi, Monopoli, and Villa. "Oral Oncology and Oral Medicine Fellowship for the General Dentist." Proceedings 35, no. 1 (2019): 23. http://dx.doi.org/10.3390/proceedings2019035023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Alamoudi, Raed Mohammed, Abdullah Hamad Alzaid, Shihnaz Mohammed Algarni, et al. "Oral health challenges in pediatric oncology patients." International Journal Of Community Medicine And Public Health 11, no. 10 (2024): 4097–100. http://dx.doi.org/10.18203/2394-6040.ijcmph20242898.

Full text

Abstract:

Pediatric oncology patients face significant oral health challenges due to the adverse effects of chemotherapy and radiation therapy. These treatments, while essential for cancer management, often lead to complications such as mucositis, xerostomia, and increased susceptibility to oral infections. Mucositis, characterized by painful inflammation and ulceration of the oral mucosa, can severely impact a child’s ability to eat, speak, and maintain oral hygiene, leading to additional health complications and potential interruptions in cancer treatment. Xerostomia, or dry mouth, resulting from radi

APA, Harvard, Vancouver, ISO, and other styles

21

Liliana Nicolau Celia, Mendes. "Nursing Interventions Promoting Adherence to Oral Medication in Oncology: Integrative Literature Review." International Journal of Science and Research (IJSR) 12, no. 7 (2023): 361–66. http://dx.doi.org/10.21275/sr23703005657.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Richardson, Paul. "Hematology/Oncology." Journal of Oral and Maxillofacial Surgery 63, no. 8 (2005): 16. http://dx.doi.org/10.1016/j.joms.2005.05.034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Carro, George W., Bruce Brockstein, Thomas A. Hensing, et al. "Evaluation of oral chemotherapy prescribing at an outpatient oncology clinic." Journal of Clinical Oncology 31, no. 31_suppl (2013): 191. http://dx.doi.org/10.1200/jco.2013.31.31_suppl.191.

Full text

Abstract:

191 Background: Oral chemotherapy’s exponentially increasing role in the treatment of malignancies continues to pose unique challenges to oncology. The American Society of Clinical Oncology (ASCO) and Oncology Nursing Society (ONS) drafted measures in the Chemotherapy Administration Safety Standards that help address some of these issues concerning oral chemotherapy. There is a lack of data describing the prescribing process for oral chemotherapy. In a retrospective chart review, prescriptions at a hospital-based outpatient oncology center were evaluated for completeness of prescribing and fol

APA, Harvard, Vancouver, ISO, and other styles

24

Comis, R. L. "Oral etoposide in oncology: An evolving role." Annals of Oncology 3 (August 1992): S63—S67. http://dx.doi.org/10.1093/annonc/3.suppl_3.s63.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Boers-Doets, C. B. "Oral Drugs: Challenges for the Oncology Nurse." Breast 36 (November 2017): S24. http://dx.doi.org/10.1016/s0960-9776(17)30635-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ratain, Mark J. "Flushing Oral Oncology Drugs Down the Toilet." Journal of Clinical Oncology 29, no. 30 (2011): 3958–59. http://dx.doi.org/10.1200/jco.2011.37.1617.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Scully, Crispian. "Oral Oncology impact factor has improved again." Oral Oncology 41, no. 9 (2005): 863–64. http://dx.doi.org/10.1016/j.oraloncology.2005.07.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Jackson, Leanne K., Douglas B. Johnson, Jeffrey A. Sosman, Barbara A. Murphy, and Joel B. Epstein. "Oral health in oncology: impact of immunotherapy." Supportive Care in Cancer 23, no. 1 (2014): 1–3. http://dx.doi.org/10.1007/s00520-014-2434-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

McLoughlin, Daniel E., Fabiola M. Moreno Echevarria, and Sherif M. Badawy. "Lessons Learned from Shared Decision Making with Oral Anticoagulants: A Literature Review and Evidence-Based Guide for Development of Oral Chemotherapy Decision Aids." Blood 142, Supplement 1 (2023): 7207. http://dx.doi.org/10.1182/blood-2023-187786.

Full text

Abstract:

Background: Oral systemic treatment is becoming an increasingly common modality of chemotherapy. By providing patients with Decision Aids (DAs), clinicians can facilitate shared decision making (SDM) and aid patients in making a treatment choice aligned with their goals and values. Though considerable research exists on DAs in oncology overall, and some products exist commercially, there is little evidence to inform the development and efficacy of DAs targeting the unique challenges of oral anticancer therapy, including difficulties with adherence and self-administration. Our objective was to

APA, Harvard, Vancouver, ISO, and other styles

30

Tymofieiev, Oleksii, and Ievgen Fesenko. "Making a Digital Editorial Bridge between Birmingham, Alabama and Kyiv Stronger." Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology 6, no. 8 (2022): 111–13. http://dx.doi.org/10.23999/j.dtomp.2022.8.1.

Full text

Abstract:

Day by day, a new scholar bridge between Birmingham, Alabama and Kyiv becomes more tangible. The cornerstone of this digital bridge was laid by Dr. Le and colleagues in 2020. Their highly productive collaboration and hard work made this transatlantic cooperation possible. The interplay between the players of a team of any profile is a key aspect of its success. That is why cooperation with Dr. Kase, from the same Department of Oral and Maxillofacial Surgery as Dr. Le became so important for the editorial board of the Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology. Des

APA, Harvard, Vancouver, ISO, and other styles

31

Mackler, Emily, Eve M. Segal, Benyam Muluneh, Kate Jeffers, and Jenna Carmichael. "2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard." Journal of Oncology Practice 15, no. 4 (2019): e346-e355. http://dx.doi.org/10.1200/jop.18.00581.

Full text

Abstract:

PURPOSE: The aim of the current work was to present a pharmacy practice standard from the Hematology/Oncology Pharmacy Association (HOPA) on the management of oral oncolytic therapy. METHODS: The HOPA Standards Committee organized a work group of oncology pharmacist specialists to create a pharmacy practice standard for the management of oral oncolytic therapy that describes the pharmacist’s role on the cancer care team, provides examples of practice tools and resources, summarizes current data related to outcomes, and discusses opportunities to enhance the care of patients with cancer who rec

APA, Harvard, Vancouver, ISO, and other styles

32

Kryazhinova, Irina A., V. V. Sadovsky, E. E. Olesov, E. V. Glazkova, P. V. Kashchenko, and V. V. Mikryukov. "THE DYNAMICS OF THE DETECTION OF MALIGNANT TUMORS OF THE LIPS AND ORAL MUCOSA IN THE MOSCOW REGION." Russian Journal of Dentistry 23, no. 1 (2019): 32–34. http://dx.doi.org/10.18821/1728-2802-2019-23-1-32-34.

Full text

Abstract:

The analysis of the prevalence of malignant neoplasms (EIT) on the lips and oral cavity according to the annual report on Russia prepared by the Moscow Oncology research Institute named after P. A. Herzen and the Moscow regional oncologic dispensary. The dynamics of the analysis was carried out for 2011 - 2017 years. The detectability of the lip and oral cavity ZNO in the Moscow region is significant. The incidence of malignant tumors of the oral cavity is more pronounced in comparison with the ZNO lips. The extent of the EIT I-II degree are more characteristic of ZNO lips, and for TESTING of

APA, Harvard, Vancouver, ISO, and other styles

33

Tariq Muhammad, Rasha, and Ali Fakhree Alzubaidee. "Oral Complications of Cancer Medication in Hemato-Oncologic Patients." Diyala Journal of Medicine 19, no. 2 (2020): 180–91. http://dx.doi.org/10.26505/djm.19025490726.

Full text

Abstract:

Background: Chemotherapy is used to treat approximately 70% of cancer patients. Oral complications secondary to chemotherapy are recorded in about 80% of hemato–oncologic patients, these complications affect the patients’ quality of life and could sometimes be fatal. Objective: To describe the oral manifestations secondary to chemotherapy medication in hemato-oncologic patients and to determine which of those oral manifestations is more common. Patients and Methods: A sample of 190 patients presented to Nanakali Hospital for blood- related diseases and cancer in Erbil. The age range of the pat

APA, Harvard, Vancouver, ISO, and other styles

34

Coyne, Kelly D., Katherine A. Trimble, Ashley Lloyd, et al. "Interventions to Promote Oral Medication Adherence in the Pediatric Chronic Illness Population: A Systematic Review From the Children’s Oncology Group." Journal of Pediatric Oncology Nursing 36, no. 3 (2019): 219–35. http://dx.doi.org/10.1177/1043454219835451.

Full text

Abstract:

Pediatric oncology protocols frequently include multiple oral medications administered at varied dosing schedules, often for prolonged periods of time. Nonadherence to protocol-directed oral medications may place patients at increased risk for morbidity and mortality. The purpose of this systematic review was to evaluate the existing body of evidence to determine best-practice recommendations regarding interventions for oral medication adherence in children and adolescents with cancer. Twenty-four articles were systematically reviewed and evaluated according to the Grading of Recommendations,

APA, Harvard, Vancouver, ISO, and other styles

35

Henry, Melissa. "Psychosocial Oncology: Optimizing Outcomes through Interdisciplinary Care in Head and Neck Oncology." Current Oncology 30, no. 7 (2023): 6859–61. http://dx.doi.org/10.3390/curroncol30070501.

Full text

Abstract:

Head and neck squamous cell carcinomas arise from the mucosal epithelium of the oral cavity (lips, buccal mucosa, anterior tongue, hard palate, floor of mouth, and retromolar trigone), nasopharynx, oropharynx (tonsils, base of tongue, soft palate, uvula, and posterior pharyngeal wall), hypopharynx, and larynx [...]

APA, Harvard, Vancouver, ISO, and other styles

36

Petrisor, Daniel, and Rui Fernandes. "Reoperative Maxillofacial Oncology." Oral and Maxillofacial Surgery Clinics of North America 23, no. 1 (2011): 161–68. http://dx.doi.org/10.1016/j.coms.2010.11.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Fayez Haif Meshail Aljunaybi. "Oral Rehabilitation in Oncology Patients: The Dentist’s Critical Role." Power System Technology 48, no. 4 (2024): 2747–67. https://doi.org/10.52783/pst.1164.

Full text

Abstract:

Cancer treatments such as chemotherapy, radiotherapy, and surgery significantly impact oral health, often leading to debilitating complications that affect patients’ quality of life. Oral mucositis, xerostomia, dental caries, infections, and osteoradionecrosis are common challenges that impair function, nutrition, and psychological well-being. The role of dentists in oncology care is critical, extending beyond routine dental procedures to include prevention, management, and comprehensive oral rehabilitation. This article explores the dentist's multidisciplinary role at every stage of oncology

APA, Harvard, Vancouver, ISO, and other styles

38

Hogle, William P., Ann Birner, and Megan Rezendes. "Oral Chemotherapy." Clinical Journal of Oncology Nursing 9, no. 1 (2005): 107–9. http://dx.doi.org/10.1188/05.cjon.107-109.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Owosho, Adepitan A., Katherine DeColibus, Beverly Hedgepeth, et al. "The Role of Dental Practitioners in the Management of Oncology Patients: The Head and Neck Radiation Oncology Patient and the Medical Oncology Patient." Dentistry Journal 11, no. 5 (2023): 136. http://dx.doi.org/10.3390/dj11050136.

Full text

Abstract:

This narrative review addresses the role of a dentist in the management of oncology patients, highlighting the oral complications that arise in head and neck radiation oncology patients and medical oncology patients. The prevention and management of these complications are discussed.

APA, Harvard, Vancouver, ISO, and other styles

40

Nicolatou-Galitis, Ourania. "Good Oral Health Can Prevent or Reduce the Severity of Oral Toxicities in Cancer Therapies." Oral 3, no. 4 (2023): 487–89. http://dx.doi.org/10.3390/oral3040039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Nguyen, Analia. "Impact of the oral chemotherapy pharmacist on direct cost avoidance and cost savings of oral oncolytics at an integrated health system." Journal of Clinical Oncology 40, no. 16_suppl (2022): e18839-e18839. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e18839.

Full text

Abstract:

e18839 Background: The impact of oncology pharmacists on patient care have been well-documented including enhanced medication safety and efficacy, increased medication adherence, improved provider and clinic burden, and increased patient and provider satisfaction. There is a scarcity of articles relating to pharmacists’ drug cost savings or cost avoidance of oncologic drugs in an oral chemotherapy management clinic within an integrated healthcare system. Cost savings and cost avoidance studies are needed to reinforce this practice and gain support and funding from hospital administration. Meth

APA, Harvard, Vancouver, ISO, and other styles

42

Miranda, Alexandre Franco. "Oncology and need of oral care for older persons." Concilium 23, no. 16 (2023): 1–14. http://dx.doi.org/10.53660/clm-1834-23m43.

Full text

Abstract:

The promotion of oral health is essential for excellent care support for older people with cancer. Educational, preventive and interventional measures based on interdisciplinary planning, with a focus on oral health, minimize the direct and indirect effects of antineoplastic treatment. This non-systematic review aims to address clinical guidelines and the dentist's performance in the treatment of older persons with cancer (chemotherapy, radiotherapy, bone marrow transplantation, oral cancer and palliative care), contributing with clinical guidelines and information to oncologists and the multi

APA, Harvard, Vancouver, ISO, and other styles

43

Sokol, Juraj, František Nehaj, Marianna Kubašková, et al. "Direct oral anticoagulants in oncology in clinical praxis." Vnitřní lékařství 65, no. 1 (2019): 45–50. http://dx.doi.org/10.36290/vnl.2019.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ramanna, Pavithra K. "Dental Management of Oral Complications in Oncology Patients." International Journal of Oral Care & Research 6, no. 1 (2018): 82–85. http://dx.doi.org/10.5005/jp-journals-10051-0154.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Vo, Liza, Anne Rain Brown, and Reagan Collins. "918: Direct Oral Anticoagulant Reversal in Oncology Patients." Critical Care Medicine 49, no. 1 (2020): 456. http://dx.doi.org/10.1097/01.ccm.0000729560.40414.70.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Park, Jeong Yun, Mikyong Kawk, HeeJung Park, et al. "Korean Oncology Nursing Society Guidelines on Oral Chemotherapy." Asian Oncology Nursing 17, no. 4 (2017): 201. http://dx.doi.org/10.5388/aon.2017.17.4.201.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Lawson, Kathy. "Oral-Dental Concerns of the Pediatric Oncology Patient." Issues in Comprehensive Pediatric Nursing 12, no. 2-3 (1989): 199–206. http://dx.doi.org/10.3109/01460868909038037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

DeCardenas, Rolando, and John S. Helfrich. "Oral Therapies and Safety Issues for Oncology Practices." Oncology Issues 25, no. 2 (2010): 40–42. http://dx.doi.org/10.1080/10463356.2010.11883499.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Anderson, Mary K., Michael J. Reff, Rebecca S. McMahon, and Deborah R. Walters. "The Role of the Oral Oncology Nurse Navigator." Oncology Issues 32, no. 5 (2017): 26–30. http://dx.doi.org/10.1080/10463356.2017.11905287.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Mahdi, I. "Book Review: Contemporary Oral Oncology: Diagnosis and Management." British Dental Journal 223, no. 9 (2017): 628. http://dx.doi.org/10.1038/sj.bdj.2017.954.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!